← Back to Search

Evidence-Based Care Strategy for Bronchiolitis (ROUTT-B Trial)

N/A

Waitlist Available

Led By Amy Tyler, MD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients age 1-23 months seen at a participating site for bronchiolitis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

ROUTT-B Trial Summary

This trial will help healthcare professionals learn how to better provide care that is evidence-based and in line with guidelines, in order to improve patient outcomes and decrease the amount of money spent on over-testing and over-treatment.

Who is the study for?

The ROUTT-B Study is for babies and toddlers aged 1-23 months diagnosed with bronchiolitis, seen at specific participating locations. Healthcare providers who treat these young patients at the sites are also involved, as well as parents of eligible children for interviews.Check my eligibility

What is being tested?

This study focuses on reducing unnecessary tests and treatments in bronchiolitis care. It aims to identify effective ways to align healthcare practices with evidence-based guidelines, potentially improving patient outcomes and cutting down on healthcare costs.See study design

What are the potential side effects?

Since this trial involves de-implementation strategies rather than medications or medical procedures, traditional side effects are not a concern. The focus is on changing healthcare provider behaviors and treatment approaches.

ROUTT-B Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child is between 1-23 months old and has bronchiolitis.

ROUTT-B Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Using survey instruments developed by the research team, measure acceptability of the de-implementation strategies for bronchiolitis patients at high-use hospital

Secondary outcome measures

Measure de-implementation effectiveness

Measure feasibility of deploying ROUTT-B from the perspectives of the quality improvement team who will deploy it.

Other outcome measures

Median length of hospitalization in hours

Proportion of patients receiving antibiotics

Stakeholders' perceptions of impact on patient outcomes

+1 more

ROUTT-B Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: High use hospitalsExperimental Treatment1 Intervention

patients 1-23 months with Bronchiolitis seen in emergency department, urgent care or admitted patients will be included; provider surveys measuring the acceptability, appropriateness, feasibility, and perceived burden of piloted strategies; review of patient data extracted from electronic health record to include baseline, intervention and post-intervention data

Group II: Low use hospital (Children's Hospital Colorado)Active Control1 Intervention

patients 1-23 months with Bronchiolitis seen in emergency department, urgent care or admitted patients will be included; review of patient data extracted from electronic health record to include data over the same time periods as the experimental groups' baseline, intervention, and post-intervention data

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,732 Previous Clinical Trials

2,123,548 Total Patients Enrolled

1 Trials studying Bronchiolitis

18 Patients Enrolled for Bronchiolitis

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,802,348 Total Patients Enrolled

1 Trials studying Bronchiolitis

44 Patients Enrolled for Bronchiolitis

Amy Tyler, MDPrincipal InvestigatorNationwide Children's Hospital

Media Library

High use hospitals Clinical Trial Eligibility Overview. Trial Name: NCT04302207 — N/A

Bronchiolitis Research Study Groups: High use hospitals, Low use hospital (Children's Hospital Colorado)

Bronchiolitis Clinical Trial 2023: High use hospitals Highlights & Side Effects. Trial Name: NCT04302207 — N/A

High use hospitals 2023 Treatment Timeline for Medical Study. Trial Name: NCT04302207 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available slots for participants in this experiment?

"According to clinicaltrials.gov, this medical study was initially posted on September 1st 2020 and its final update occurred November 22nd 2022. As such, patient recruitment is no longer ongoing; however, 39 other trials are currently enrolling patients."

Answered by AI

What criteria must one meet to be considered a viable participant in this experiment?

"This clinical trial has a total enrollment of 20,000 participants aged 1 Month to 80 years who are currently suffering from bronchiolitis. Furthermore, these patients must have been seen at participating sites for the condition and their parents should be available for interviews."

Answered by AI

Does this experiment accept participants who are in their seventies or older?

"This clinical trial necessitates that applicants must be between 1 Month and 80 years old to qualify. There are 24 spots available for minors, while those aged over 65 have 18 opportunities available."

Answered by AI

Recent research and studies

PediatricsJournal

Interventions to Reduce Over-utilized Tests and Treatments in Bronchiolitis

Tyler, Amy, Paige Krack, Leigh Anne Bakel, Kimberly O’Hara, Douglas Scudamore, Irina Topoz, Julia Freeman, et al.. 2018. “Interventions to Reduce Over-utilized Tests and Treatments in Bronchiolitis”. Pediatrics. American Academy of Pediatrics (AAP). doi:10.1542/peds.2017-0485.

clinicaltrials.govStudy

The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study

2020. "The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04302207.

All > Bronchiolitis